세계의 디지털 병리학 시장 규모는 2024년에 11억 6,000만 달러로 평가되었고, 2030년까지의 CAGR은 11.46%를 나타내, 예측 기간에는 22억 3,000만 달러에 달할 것으로 예상됩니다.
디지털 병리학은 디지털화된 샘플 슬라이드에서 데이터를 추출하는 데 중점을 둔 전문 분야입니다. 디지털 병리학은 컴퓨터 기반 기술과 가상 현미경을 활용하여 이미지 기반 정보를 얻을 수 있습니다. 이 혁신적인 접근 방식은 세계 병리 검사실의 효율성, 워크플로우 및 수익을 크게 향상시키고 있습니다. 유리 슬라이드를 디지털화하면 사용자는 컴퓨터 모니터에서 쉽게 관리, 공유, 탐색 및 분석할 수 있습니다. 디지털 병리학은 1차 질환 진단, 진단 결정 지원, 수술 중 진단, 진단 컨설팅, 연수의 및 의학 교육, 피어 리뷰, 매뉴얼 및 반정량 면역조직화학(IHC) 검토, 임상 조사 등 다양한 분야에서 응용되고 있습니다. 그 도입은 검사실의 효율 개선과 진단 결과의 신속화로 이어지고 있습니다. 교육 분야, 의약품 개발, 조직 기반 연구, 질병 진단 등으로부터의 지지가 높아지고 있는 가운데, 디지털 병리학은 헬스케어 분야에서 필수적이고 입증된 기술로서 급속히 인지되고 있습니다.
| 시장 개요 | |
|---|---|
| 예측 기간 | 2026-2030년 |
| 시장 규모 : 2024년 | 11억 6,000만 달러 |
| 시장 규모 : 2030년 | 22억 3,000만 달러 |
| CAGR : 2025-2030년 | 11.46% |
| 급성장 부문 | 질병 진단 |
| 최대 시장 | 북미 |
만성 질환의 부담 증가와 정확하고 시기 적절한 진단에 대한 수요 증가는 디지털 병리학의 채용을 촉진하는 주요 요인이되었습니다. 암, 심혈관 질환, 전염병 세계의 이환율이 계속 상승하고 있는 가운데, 건강 관리 제산업체는 진단을 간소화하고 정확성을 향상시키는 첨단 기술을 요구하고 있습니다. 디지털 병리학은 고해상도 이미지 분석을 지원하여 원격 액세스를 통한 두 번째 의견을 용이하게 합니다. 이 기능은 진단 정확도를 향상시킬 뿐만 아니라 소요 시간을 단축하고, 특히 복잡한 사례나 중요한 사례에서 보다 신속한 임상적 의사결정과 환자 결과의 개선을 가능하게 합니다.
실험실 효율성
고비용 디지털 병리학
원격병리검사 및 원격진찰
Global Digital Pathology Market was valued at USD 1.16 billion in 2024 and is expected to reach USD 2.23 billion in the forecast period with a CAGR of 11.46% through 2030. Digital pathology is a specialized field that focuses on extracting data from digitized specimen slides. By utilizing computer-based technology and virtual microscopy, digital pathology enables the acquisition of image-based information. This innovative approach has significantly enhanced the efficiency, workflow, and revenue of pathology labs worldwide. Through the conversion of glass slides into digital counterparts, users can effortlessly manage, share, view, and analyze them on a computer monitor. Digital pathology finds applications in various areas, including primary disease diagnosis, diagnostic decision support, intraoperative diagnosis, diagnostic consultation, resident and medical training, peer review, manual and semi-quantitative immunohistochemistry (IHC) review, and clinical research. Its implementation has led to improved laboratory efficiency and faster diagnostic results. With growing support from the education sector, drug development, tissue-based research, and disease diagnosis, digital pathology is rapidly gaining recognition as an essential and proven technology in the healthcare sector.
| Market Overview | |
|---|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 1.16 Billion |
| Market Size 2030 | USD 2.23 Billion |
| CAGR 2025-2030 | 11.46% |
| Fastest Growing Segment | Disease Diagnosis |
| Largest Market | North America |
The increasing burden of chronic diseases and the growing demand for precise and timely diagnostics are major factors driving the adoption of digital pathology. As the global incidence of cancer, cardiovascular conditions, and infectious diseases continues to rise, healthcare providers are seeking advanced technologies that streamline diagnosis and improve accuracy. Digital pathology supports high-resolution image analysis and facilitates second opinions through remote access, which is particularly beneficial in underserved and rural regions. This capability not only enhances diagnostic accuracy but also reduces turnaround times, enabling faster clinical decision-making and better patient outcomes, especially in complex or critical cases.
Key Market Drivers
Enhanced Lab Efficiency
Digital pathology dramatically improves laboratory efficiency by accelerating image analysis and report turnaround. Recent data shows that slide review times have decreased by up to 40% after digital adoption, allowing pathologists to process more cases daily. Additionally, remote consultation speeds have improved by 50%, as specialists can collaborate in real time without physical slides. These efficiency gains not only alleviate workload but also shorten patient wait times for critical diagnostic results. With quicker access to digital slides, labs can streamline workflows, reduce bottlenecks, and improve overall operational performance in both clinical and research settings.
By enabling remote access to pathology images, digital platforms foster seamless collaboration among healthcare professionals. Specialists can review cases and consult across geographic locations instantly, eliminating delays tied to shipping and physical slide transfer. Studies show that 75% of pathologists report enhanced diagnostic confidence through virtual peer reviews. This collaborative environment promotes accurate diagnoses and accelerates treatment decisions-ultimately improving patient outcomes. As cross-functional teams, including oncologists and geneticists, access slides simultaneously, multidisciplinary care coordination is significantly enhanced, reinforcing the growing need for digital pathology in modern healthcare systems.
Another major advantage is cost reduction. Digital pathology eliminates phased costs associated with producing, storing, and transporting glass slides. For example, laboratories have reported up to 60% savings on shipping and archiving expenses. Storage facilities that once required extensive physical archive space are now replaced by secure digital repositories, reducing overhead. Additionally, digital retrieval systems enable rapid, on-demand access to historical slides, supporting longitudinal studies and clinical audits. This shift toward digital archives reduces operational complexity, enhances data integrity, and cuts total ownership costs-strengthening the case for digital investments.
Key Market Challenges
High Cost of Digital Pathology
The high cost of digital pathology and the low adoption rate in emerging and underdeveloped countries present obstacles to the market's growth. Augmenting addresses this challenge by offering a modular hardware platform with integrated digital pathology software applications, helping to keep costs low. Implementing digital pathology systems requires significant upfront investment in scanners, storage infrastructure, and software solutions. The expenses associated with digitizing slides, maintaining digital archives, and training personnel can be substantial, especially for small laboratories or healthcare facilities with limited budgets. Furthermore, integrating digital pathology into existing laboratory workflows and the need for IT support and infrastructure upgrades can pose challenges for some organizations.
Key Market Trends
Telepathology and Remote Consultation
The increasing adoption of telepathology enables remote diagnosis and consultation, allowing pathologists to collaborate and provide expert opinions without being limited by geographical constraints. Telepathology has gained significant prominence during the COVID-19 pandemic, as it facilitates remote working and minimizes the risk of exposure for pathologists. For instance, pathologists can remotely review and discuss cases with colleagues, participate in multidisciplinary tumor boards, or offer consultations to underserved areas or regions facing a shortage of pathology expertise. The increasing preference for computer-aided diagnosis, integrating image processing, physics, mathematics, and computing algorithms, facilitates efficient disease detection. It also assists in evaluating anatomic structures of interest, quantifying disease progression and risk assessment, thereby stimulating market growth. Notably, companies like Olympus offer a range of tools for remote slide sharing and image processing, contributing to anticipated market expansion in the upcoming years. In April 2020, Leica Biosystems obtained FDA approval for the Aperio AT2 DX Scanner and Aperio WebViewer, enabling remote diagnosis during the pandemic. Additionally, during this emergency, Phillips also received FDA approval for its IntelliSite Pathology Solution, further supporting remote diagnosis.
In this report, the Global Digital Pathology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Digital Pathology Market, By Product Type:
Digital Pathology Market, By Application:
Digital Pathology Market, By End User:
Digital Pathology Market, By Region:
Company Profiles: Detailed analysis of the major companies present in the Global Digital Pathology Market.
Global Digital Pathology market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: